Wang, Qian#；Su, Shan#；Xue, Jing#；Yu, Fei；Pu, Jing；Bi, Wenwen；Xia, Shuai；Meng, Yu；Wang, Cong；Yang, Wenqian；Xu, Wei；Zhu, Yun；Zheng, Qinwen；Qin, Chuan*；Jiang, Shibo*；Lu, Lu*. An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells. Sci Transl Med. 2020 Jun 3;12(546):eaaz2254，2020
Zhou, Jie#; Xu, We#; Liu, Zezhong#; Wang, Chao#; Xia, Shuai; Lan, Qiaoshuai; Cai, Yanxing; Su, Shan; Pu, Jing; Xing, Lixiao; Xie, Youhua*; Lu, Lu*; Jiang, Shibo*; Wang, Qian*. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases . Acta Pharm Sin B. 2021 Aug 2. doi: 10.1016/j.apsb.2021.07.026. Online ahead of print, 2021
Xia, Shuai#; Lan, Qiaoshuai#; Su, Shan#; Wang, Xinling#; Xu, Wei; Liu, Zezhong; Zhu, Yun; Wang, Qian*; Lu, Lu*; Jiang, Shibo*. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther. 5(1):92; 2020
Wang, Qian#; Dai, Yanyan#; Sun, Zhiwu; Su, Xiaojie; Yu, Yufeng; Hua, Chen; Xu, Wei; Jiang, Shibo*; Lu, Lu*. HIV-1 Env DNA prime plus gp120 and gp70-V1V2 boosts induce high level of V1V2-specific IgG and ADCC responses and low level of Env-specific IgA response: implication for improving RV144 vaccine regimen. Emerg Microbes Infect. 6(11):e102, 2017
Qi, Qianqian#; Wang, Qian#; Chen, Weizao; Du, Lanying; Dimitrov, Dimiter S.; Lu, Lu*; Jiang, Shibo*. HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions. Emerg Microbes Infect. 6(6):e59, 2017
